Misplaced Pages

This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (March 2021) (Learn how and when to remove this message)

Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America. Recently, the US FDA issued a warning letter due to "evidence that the company was keeping incomplete documentation and did not adequately investigate instances of microbial contamination."

References

1. Mezher, Michael (27 September 2016). "The Rooms Have Never Been Cleaned': Two New FDA Warning Letters for Chinese Manufacturers". RAPS. Retrieved 28 September 2016.
2. "Hebei Yuxing Bio-Engineering Co Ltd 9/6/16 - Warning Letter 320-16-31". US FDA. 6 September 2016. Retrieved 28 September 2016.

v t e Pharmaceutical companies of China

CanSino Biologics CSPC Zhongrun China Nepstar Fosun Pharmaceutical Guangzhou Pharmaceuticals Guangyuyuan Guizhentang Pharmaceutical Company Harbin Pharmaceutical Group Hebei Yuxing Bio-Engineering Co. Ltd Huadong Medicine Jilin Aodong Medicine Lijun International Pharmaceutical (Holding) Co. Ltd. Kunming Pharmaceutical Corporation Nanjing Ange Pharmaceutical North China Pharmaceutical Group Salubris Pharmaceuticals Shanghai Pharmaceuticals Holding Co., Ltd. Shenzhen Kangtai Biological Products Shijiazhuang Pharma Group Sihuan Pharmaceutical Simcere Pharmaceutical China National Pharmaceutical Group Sinopharm Group Sinovac Biotech Tasly Tong Ren Tang Xiangxue Pharmaceutical Yangtze River Pharmaceutical Group Yunnan Baiyao Group WuXi AppTec

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This Chinese corporation or company article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Pharmaceutical companies of China
• Pharmacology stubs
• Chinese company stubs